Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
1999-6-24
pubmed:abstractText
The extracellular (interstitial) pH (pHe) of solid tumours is significantly more acidic compared to normal tissues. In-vitro, low pH reduces the uptake of weakly basic chemotherapeutic drugs and, hence, reduces their cytotoxicity. This phenomenon has been postulated to contribute to a 'physiological' resistance to weakly basic drugs in vivo. Doxorubicin is a weak base chemotherapeutic agent that is commonly used in combination chemotherapy to clinically treat breast cancers. This report demonstrates that MCF-7 human breast cancer cells in vitro are more susceptible to doxorubicin toxicity at pH 7.4, compared to pH 6.8. Furthermore 31P-magnetic resonance spectroscopy (MRS) has shown that the pHe of MCF-7 human breast cancer xenografts can be effectively and significantly raised with sodium bicarbonate in drinking water. The bicarbonate-induced extracellular alkalinization leads to significant improvements in the therapeutic effectiveness of doxorubicin against MCF-7 xenografts in vivo. Although physiological resistance to weakly basic chemotherapeutics is well-documented in vitro and in theory, these data represent the first in vivo demonstration of this important phenomenon.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/10362108-10796075, http://linkedlifedata.com/resource/pubmed/commentcorrection/10362108-13298683, http://linkedlifedata.com/resource/pubmed/commentcorrection/10362108-1333263, http://linkedlifedata.com/resource/pubmed/commentcorrection/10362108-1676902, http://linkedlifedata.com/resource/pubmed/commentcorrection/10362108-1996613, http://linkedlifedata.com/resource/pubmed/commentcorrection/10362108-2545340, http://linkedlifedata.com/resource/pubmed/commentcorrection/10362108-27851, http://linkedlifedata.com/resource/pubmed/commentcorrection/10362108-3205159, http://linkedlifedata.com/resource/pubmed/commentcorrection/10362108-3812988, http://linkedlifedata.com/resource/pubmed/commentcorrection/10362108-6097949, http://linkedlifedata.com/resource/pubmed/commentcorrection/10362108-7083221, http://linkedlifedata.com/resource/pubmed/commentcorrection/10362108-7909602, http://linkedlifedata.com/resource/pubmed/commentcorrection/10362108-8611717, http://linkedlifedata.com/resource/pubmed/commentcorrection/10362108-9049456, http://linkedlifedata.com/resource/pubmed/commentcorrection/10362108-9106927, http://linkedlifedata.com/resource/pubmed/commentcorrection/10362108-9216640, http://linkedlifedata.com/resource/pubmed/commentcorrection/10362108-9220288, http://linkedlifedata.com/resource/pubmed/commentcorrection/10362108-9296948, http://linkedlifedata.com/resource/pubmed/commentcorrection/10362108-9422471, http://linkedlifedata.com/resource/pubmed/commentcorrection/10362108-9584137, http://linkedlifedata.com/resource/pubmed/commentcorrection/10362108-9890558
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0007-0920
pubmed:author
pubmed:issnType
Print
pubmed:volume
80
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1005-11
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1999
pubmed:articleTitle
Enhancement of chemotherapy by manipulation of tumour pH.
pubmed:affiliation
Arizona Cancer Center, Tucson 85724-5024, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, U.S. Gov't, Non-P.H.S.